Reaction

Herpes Zoster Disseminated reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 782 reports · 26 co-occurring drugs

As of the last recalculation, Herpes Zoster Disseminated appears in 782 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 41.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Basiliximab1841.741.7
Alemtuzumab1926.826.8
Melphalan Hydrochloride2325.125.1
Baricitinib925.125.1
Ganciclovir923.723.7
Ganciclovir Sodium922.922.9
Mycophenolate Mofetil10222.822.9
Mycophenolate Mofetil Hydrochloride10222.822.8
Melphalan1922.822.8
Sirolimus1122.022.0
Piperacillin And Tazobactam1021.121.1
Tacrolimus Ointment 0.1%8620.520.5
Tacrolimus Extended-Release Capsules8620.520.5
Mycophenilic Acid1519.619.6
Bortezomib6019.319.3
Tacrolimus9919.119.1
Bendamustine Hcl1017.417.4
Busulfan1017.117.1
Entecavir716.116.1
Miconazole Nitrate515.315.3
Fludarabine Phosphate2013.913.9
Bendamustine Hydrochloride613.413.4
Daratumumab1711.611.6
Upadacitinib3010.110.1
Voclosporin39.29.2
Carfilzomib98.68.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.